Explore our latest updates, industry trends, and deep dives into biotechnology.
Nucleos Biotech participated in the Nucleate Germany Activator 2026 as an expert reviewer during the Application and Market Risk Workshop held on March 12, 2026. Dr. Ibrahim Chokri, co-founder and scientific lead, provided strategic mentorship to early-stage biotech companies, including support on market positioning, investment readiness, and commercialization pathways. The engagement reflects Nucelos’ mission to bridge European biotech innovation with GCC capital and strategic networks.